Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.
Saibara
T
T
Onishi
S
S
Ogawa
Y
Y
Yoshida
S
S
Enzan
H
H
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001629:Bezafibrate / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D005234:Fatty Liver / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control*; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control*; D013629:Tamoxifen / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D000960:Hypolipidemic Agents; D013629:Tamoxifen; D001629:Bezafibrate